Concepedia

Jon G. Sundelof

JG

Statistics

Publications

11

Citations

1.3K

H-Index

10

Active since

1980

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Jon G. Sundelof is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacology, antibacterial pharmacology, and drug disposition.

Publications per year

1980–1999

11

Publications

11

Metabolism of Thienamycin and Related Carbapenem Antibiotics by the Renal Dipeptidase, Dehydropeptidase-I

H Kropp, Jon G. Sundelof, Richard Hajdu et al. · Antimicrobial Agents and Chemotherapy · 1982 · 340 citations · Full text

, , +17

Antibiotic sensitization using biphenyl tetrazoles as potent inhibitors of Bacteroides fragilis metallo-β-lactamase

Jeffrey H. Toney, Paula M.D. Fitzgerald, Nandini Grover-Sharma et al. · Chemistry & Biology · 1998 · 239 citations · Full text

, , +15

MK0787 (N-formimidoyl thienamycin): evaluation of in vitro and in vivo activities

H Kropp, Jon G. Sundelof, Jean S. Kahan et al. · Antimicrobial Agents and Chemotherapy · 1980 · 194 citations · Full text

, , +14

Preliminary animal pharmacokinetics of the parenteral antifungal agent MK-0991 (L-743,872)

Richard Hajdu, R Thompson, Jon G. Sundelof et al. · Antimicrobial Agents and Chemotherapy · 1997 · 167 citations · Full text

, , +17

Urinary Recovery of <i>N</i> -Formimidoyl Thienamycin (MK0787) as Affected by Coadministration of <i>N</i> -Formimidoyl Thienamycin Dehydropeptidase Inhibitors

S. Ragnar Norrby, Kjell Alestig, Barbro Björnegård et al. · Antimicrobial Agents and Chemotherapy · 1983 · 160 citations · Full text

, , +13

1–5 of 11